Dow Dips Over 400 Points; Crude Oil Rises 2%
U.S. stocks turned sharply lower toward the end of trading, with the Dow Jones dropping more than 400 points on Tuesday.
Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.
Here’s Why Cognyte Software Shares Are Crashing Premarket
Cognyte Software Ltd (NASDAQ:CGNT) reported a first-quarter FY23 non-GAAP revenue decline of 24.7% year-on-year to $86.7 million, missing the consensus of…
Recap: Cognyte Software Q1 Earnings
Cognyte Software (NASDAQ:CGNT) reported its Q1 earnings results on Tuesday, June 28, 2022 at 07:10 AM.
Here's what investors need to know about the announcement.
Earnings
Cognyte Software reported an EPS of $-0.79.
Earnings Scheduled For June 28, 2022
Companies Reporting Before The Bell
• Jupai Hldgs (NYSE:JP) is projected to report earnings for its first quarter.
Preview: Cognyte Software’s Earnings
Cognyte Software (NASDAQ:CGNT) is set to give its latest quarterly earnings report on Tuesday, 2022-06-28. Here's what investors need to know before the announcement.
Analysts estimate that Cognyte Software will report an earnings per share (EPS) of $0.10.
Evercore ISI Group Maintains Outperform on Cognyte Software, Lowers Price Target to $12
Evercore ISI Group analyst Kirk Materne maintains Cognyte Software (NASDAQ:CGNT) with a Outperform and lowers the price target from $25 to $12.
Stifel Maintains Buy on Cognyte Software, Lowers Price Target to $13
Stifel analyst Brad Reback maintains Cognyte Software (NASDAQ:CGNT) with a Buy and lowers the price target from $21 to $13.